Senior insider sale
Chief Commercial Officer at OCULAR THERAPEUTIX, INC — senior position signals high conviction
$27.9K
3.05K shares
What this filing means
MEYERS STEVE LAWRENCE plans to sell 3.05K shares of OCULAR THERAPEUTIX, INC valued at approximately $27.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/2/2026ACC: 0001950047-26-000808
Officer· Chief Commercial Officer
Since Jun 2025
3.05K
Shares to sell
$27.9K
Approx. market value
3.05K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Not Applicable
1/30/2026
3.05KTotal acquired3.05K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/30/2026 | Restricted stock vesting under a registered plan Not Applicable | 3.05K | — |
| Total | 3.05K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.05K
Market value
$27.9K
2/2/2026
Total
Units
3.05K
Value
$27.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/2/2026 | 3.05K | $27.9K | NASDAQ | Planned |
| Total | 3.05K | $27.9K | ||